Owner only: item control page
Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry
Haist, Maximilian
, Stege, Henner, Lang, Berenice Mareen, Tsochataridou, Aikaterini, Salzmann, Martin, Mohr, Peter, Schadendorf, Dirk, Ugurel, Selma
, Placke, Jan-Malte, Weichenthal, Michael
, Gutzmer, Ralf
, Leiter, Ulrike
, Kaatz, Martin, Haferkamp, Sebastian, Berking, Carola, Heppt, Markus
, Tschechne, Barbara, Schummer, Patrick, Gebhardt, Christoffer
, Grabbe, Stephan and Loquai, Carmen
(2022)
Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry.
Cancers 14 (22), p. 5543.
Date of publication of this fulltext: 29 Feb 2024 13:02
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Cancers | ||||
| Publisher: | MDPI | ||||
|---|---|---|---|---|---|
| Place of Publication: | BASEL | ||||
| Volume: | 14 | ||||
| Number of Issue or Book Chapter: | 22 | ||||
| Page Range: | p. 5543 | ||||
| Date | 2022 | ||||
| Institutions | Medicine > Lehrstuhl für Dermatologie und Venerologie | ||||
| Identification Number |
| ||||
| Keywords | NONMELANOMA SKIN-CANCER; REAL-WORLD DATA; ADVANCED MELANOMA; OPEN-LABEL; CEMIPLIMAB; PEMBROLIZUMAB; IPILIMUMAB; THERAPY; advanced cutaneous squamous cell carcinoma; checkpoint inhibitor therapy; cemiplimab; immunosuppression; response durability; real-world data | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 57730 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric